共 70 条
- [11] Amano K(2022)Advances in Hemophilia A Management Adv Pediatr 69 133-1195
- [12] Hagiwara T(2015)Hemophilia B: molecular pathogenesis and mutation analysis J Thromb Haemost 13 1184-S14
- [13] Garagiola I(2022)Challenges and knowledge gaps facing hemophilia carriers today: Perspectives from patients and health care providers Res Pract Thromb Haemost 6 e12783-379
- [14] Mortarino M(2020)Hemophilia carriers: quality of life and management at different life stages Blood Coagul Fibrinolysis 31 S12-748
- [15] Siboni SM(2014)Mutation analysis of a cohort of US patients with hemophilia B Am J Hematol 89 375-e92
- [16] Whitaker S(2018)Mutation Spectrum and Genotype-Phenotype Analyses in a Pakistani Cohort With Hemophilia B Clin Appl Thromb Hemost 24 741-E96
- [17] Aiston H(2021)Mutation analysis in the F8 gene in 485 families with haemophilia A and prenatal diagnosis in China Haemophilia 27 e88-765
- [18] Hung WT(2017)Utility of factor V and factor V to von Willebrand factor ratio in identifying 277 unselected carriers of hemophilia A Am J Hematol 92 E94-185
- [19] Punt MC(2015)Haemophilia A carriers experience reduced health-related quality of life Haemophilia 21 761-e60
- [20] Aalders TH(2019)Hemophilia carrier’s awareness, diagnosis, and management in emerging countries: a cross-sectional study in Cote d’Ivoire (Ivory Coast) Orphanet J Rare Dis 14 26-S16